Booz Allen Hamilton anticipates significant growth in its cybersecurity business. Read why I reiterate a Strong Buy rating ...

Target Resources cut its dividend in 2020 to repay debt faster, reflecting its aggressive growth strategy. See why TRGP stock ...

Global Medical REIT's Q3-2024 results show flat rental revenue and AFFO. Check out a few concerns with GMRE stock and why it ...

The acquisition reshapes FREYR Battery into a profitable growth company while providing immediate revenue streams. See why ...

Microsoft's Intelligent Cloud segment sees growth from Azure AI adoption. Read why I remain bullish on MSFT stock and ...

SPDR S&P Insurance ETF's equal-weighted approach and high volume mitigate single-stock risk. Find out why KIE is a Buy.

David Abrams’ 13F portfolio value increased from $5.11B to $6.23B in Q3 2024, with the top three stakes comprising ~66%. The ...

Meta Platforms delivered strong Q3 results, but it's not the right time to initiate a position in the company. See why META ...

Analysis of the potential impact of Trump's policies on growth and the stock market, including tariffs, tax cuts, and ...

Maxim Power's transition to a new plant and market shift increase shareholder value. Click here to read why MXG:CA stock is a ...

Invesco Water Resources is the largest of the water ETFs. Read why I'm not convinced PHO's portfolio is a particularly ...

I reiterate a 'Sell' rating on IDEXX due to weak U.S. clinical visits and demand, with a one-year price target of $400 per ...